VEGFR2/CD309 antibody
Quick Overview for VEGFR2/CD309 antibody (ABIN7670768)
Target
See all VEGFR2/CD309 (VEGFR2) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Purpose
- VEGF R2/KDR Polyclonal Antibody
-
Purification
- Antigen Affinity Purification
-
Immunogen
- Recombinant Human VEGF R2/KDR protein expressed by Mammalian
-
Isotype
- IgG
-
-
-
-
Application Notes
- ELISA Capture 2-8 μg/mL,ELISA Detector 0.1-0.4 μg/mL
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1 mg/mL
-
Buffer
- Sterile PBS , pH 7.4
-
Preservative
- Without preservative
-
Handling Advice
- Avoid freeze / thaw cycles. This preparation contains no preservatives, thus it should be handled under aseptic conditions.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store at 4°C Valid for 1 month or -20°C Valid for 12 months
-
Expiry Date
- 12 months
-
-
- VEGFR2/CD309 (VEGFR2) (VEGF Receptor 2 (VEGFR2))
-
Alternative Name
- VEGF R2/KDR
-
Background
- VEGFR2,CD309,FLK1,Vascular endothelial growth factor (VEGF) is a major growth factor for endothelial cells. This gene encodes one of the two receptors of the VEGF. This receptor, known as kinase insert domain receptor, is a type III receptor tyrosine kinase. It functions as the main mediator of VEGF-induced endothelial proliferation, survival, migration, tubular morphogenesis and sprouting. The signalling and trafficking of this receptor are regulated by multiple factors, including Rab GTPase, P2Y purine nucleotide receptor, integrin alphaVbeta3, T-cell protein tyrosine phosphatase, etc.. Mutations of this gene are implicated in infantile capillary hemangiomas.
-
UniProt
- P35968
-
Pathways
- RTK Signaling, Glycosaminoglycan Metabolic Process, Signaling Events mediated by VEGFR1 and VEGFR2, Growth Factor Binding, Regulation of long-term Neuronal Synaptic Plasticity, VEGF Signaling
Target
-